Endocrine Abstracts

Immune checkpoint inhibitors are a new group of monoclonal antibodies against checkpoints in normal T Lymphocyte activation enabling immune system activation in order to target cancer cells. First used for treatment of melanoma in 2011, they are currently indicated for management of an increasing spectrum of malignancy. Endocrinopathy secondary to checkpoint inhibitors is commonly observed. This has led to a new group of patients requiring specialist investigation, management,...

Abstract Unavailable...

Over the last two decades, the menopause management pendulum has swung wildly from very few women wanting HRT to so many women wanting it, with the recent increased awareness in the media, that shortages have occurred. Some narratives have resulted in greater fear about menopause and unrealistic expectations about HRT. Conflicting reports have led to much confusion among women. In this talk, I will discuss the implications of menopause today for women in context, including rel...

Abstract Unavailable...